Markus Nauck

4.0k total citations
56 papers, 3.1k citations indexed

About

Markus Nauck is a scholar working on Surgery, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Markus Nauck has authored 56 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 15 papers in Epidemiology and 13 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Markus Nauck's work include Lipoproteins and Cardiovascular Health (10 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Markus Nauck is often cited by papers focused on Lipoproteins and Cardiovascular Health (10 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Markus Nauck collaborates with scholars based in Germany, Switzerland and Austria. Markus Nauck's co-authors include Michael Roth, Winfried März, Heinrich Wieland, Bernhard R. Winkelmann, André P. Perruchoud, Eleni Papakonstantinou, George Karakiulakis, Robert Ritzel, Jens J. Holst and Wolff Schmiegel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and The Journal of Experimental Medicine.

In The Last Decade

Markus Nauck

56 papers receiving 3.0k citations

Peers

Countries citing papers authored by Markus Nauck

Since Specialization

Citations

This map shows the geographic impact of Markus Nauck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Nauck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Nauck more than expected).

Fields of papers citing papers by Markus Nauck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Nauck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Nauck. The network helps show where Markus Nauck may publish in the future.

Co-authorship network of co-authors of Markus Nauck

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Nauck. A scholar is included among the top collaborators of Markus Nauck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Nauck. Markus Nauck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeted next-generation sequencing identifies a homozygous nonsense mutation in ABHD12, the gene underlying PHARC, in a family clinically diagnosed with Usher syndrome type 3 2012 ·Orphanet Journal of Rare Diseases ·Tobias Eisenberger, Rima Slim, Ahmad M. Mansour, Markus Nauck, Gudrun Nürnberg, Peter Nürnberg, Christian Decker, Claudia Dafinger, Inga Ebermann, Carsten Bergmann, Hanno J. Bolz	60
2	Forensic analysis of carbohydrate-deficient transferrin (CDT) by HPLC—Statistics and extreme CDT values 2007 ·Forensic Science International ·Torsten Arndt, (unknown), (unknown), Markus Nauck, (unknown), (unknown)	14
3	Adhesion molecules in pediatric intensive care patients with organ dysfunction syndrome 2006 ·Intensive Care Medicine ·Marcus Krueger, Andrea Heinzmann, Markus Nauck	12
4	Primary biliary cirrhosis is not a clinical condition for increased carbohydrate-deficient transferrin: Experience with four independent CDT analysis methods 2006 ·Clinica Chimica Acta ·Torsten Arndt, Ursula Meier, Markus Nauck, Axel M. Gressner	19
5	Genotype-corrected reference values for serum angiotensin-converting enzyme 2006 ·European Respiratory Journal ·Heike Biller, Gernot Zissel, (unknown), Markus Nauck, Andrea Busse Grawitz, Joachim Müller‐Quernheim	65
6	Adiponectin serum concentrations in men with coronary artery disease: The LUdwigshafen RIsk and Cardiovascular Health (LURIC) study 2005 ·Clinica Chimica Acta ·Stefan Pilz, Winfried Maerz, Gisela Weihrauch, Karine Sargsyan, Gunter Almer, Markus Nauck, Bernhard O. Boehm, Bernhard R. Winkelmann, Harald Mangge	41
7	Association of angiotensinogen haplotypes with angiotensinogen levels but not with blood pressure or coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study 2004 ·Journal of Molecular Medicine ·Wilfried Renner, Markus Nauck, Bernhard R. Winkelmann, Michael M. Hoffmann, Hubert Scharnagl, (unknown), Bernhard O. Boehm, (unknown)	43
8	C(−260)T polymorphism in the promoter of the CD14 gene is not associated with coronary artery disease and myocardial infarction in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study 2002 ·The American Journal of Cardiology ·Markus Nauck, Bernhard R. Winkelmann, Michael M. Hoffmann, Bernhard Böhm, Heinrich Wieland, Winfried März	20
9	Effects of Glucagon-Like Peptide 1 on Counterregulatory Hormone Responses, Cognitive Functions, and Insulin Secretion during Hyperinsulinemic, Stepped Hypoglycemic Clamp Experiments in Healthy Volunteers 2002 ·The Journal of Clinical Endocrinology & Metabolism ·Michael A. Nauck, Markus M. Heimesaat, (unknown), Jens J. Holst, Markus Nauck, Robert Ritzel, M. Hüfner, Wolff Schmiegel	471
10	FH-Freiburg: a novel missense mutation (C317Y) in growth factor repeat A of the low density lipoprotein receptor gene in a German patient with homozygous familial hypercholesterolemia 2000 ·Atherosclerosis ·Markus Nauck, Hubert Scharnagl, Henrik Nissen, (unknown), (unknown), Matthias Nauck, Heinrich Wieland, Winfried März	4
11	Evaluation of the Roche Diagnostics LightCycler-Factor V Leiden Mutation Detection Kit and the LightCycler-Prothrombin Mutation Detection Kit 2000 ·Clinical Biochemistry ·Markus Nauck, Winfried März, Heinrich Wieland	17
12	The effects of lifibrol (K12.148) on the cholesterol metabolism of cultured cells: evidence for sterol independent stimulation of the LDL receptor pathway 2000 ·Atherosclerosis ·Hubert Scharnagl, (unknown), R. Löser, Markus Nauck, (unknown), Nikola Jeck, Heinrich Wieland, Werner Groß, Winfried März	6
13	Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease 1999 ·American Heart Journal ·Bernhard R. Winkelmann, Andreas Russ, Markus Nauck, (unknown), Bernhard Böhm, V. Maier, Rainer B. Zotz, G. Matheis, (unknown), Heinrich Wieland, Werner Groß, D. J. Galton, Winfried März	99
14	Rapid genotyping of human platelet antigen 1 (HPA‐1) with fluorophore‐labelled hybridization probes on the LightCycler^TM 1999 ·British Journal of Haematology ·Markus Nauck, (unknown), Matthias Nauck, Winfried März, Heinrich Wieland	34
15	Apolipoprotein E2 (Arg136 → Cys) mutation in the receptor binding domain of apoE is not associated with dominant type III hyperlipoproteinemia 1998 ·Journal of Lipid Research ·Winfried März, Michael M. Hoffmann, Hubert Scharnagl, (unknown), Minchun Chen, Markus Nauck, Giso Feussner, Heinrich Wieland	20
16	Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells 1998 ·European Journal of Pharmacology ·Markus Nauck, George Karakiulakis, André P. Perruchoud, Eleni Papakonstantinou, Michael Roth	375
17	Induction of Vascular Endothelial Growth Factor by Platelet-Activating Factor and Platelet-Derived Growth Factor is Downregulated by Corticosteroids 1997 ·American Journal of Respiratory Cell and Molecular Biology ·Markus Nauck, Michael Roth, M. Tamm, Oliver Eickelberg, Heinrich Wieland, P Stulz, A Perruchoud	181
18	Human Connective Tissue Growth Factor Is Expressed in Advanced Atherosclerotic Lesions 1997 ·Circulation ·Barry S. Oemar, (unknown), Jean‐Marie Garnier, Dai-Do Do, Nelson Godoy, Markus Nauck, (unknown), Joachim Rupp, Michael Pech, (unknown)	275
19	Platelet-activating factor exerts mitogenic activity and stimulates expression of interleukin 6 and interleukin 8 in human lung fibroblasts via binding to its functional receptor. 1996 ·The Journal of Experimental Medicine ·Michael Roth, Markus Nauck, Shída Yousefi, M. Tamm, Kurt Blaser, A Perruchoud, Hans‐Uwe Simon	77
20	Ca2+-channel blockers modulate the expression of interleukin-6 and interleukin-8 genes in human vascular smooth muscle cells 1995 ·Journal of Molecular and Cellular Cardiology ·(unknown), Michael Roth, Markus Nauck, M. Tamm, L H Block	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact